Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System

NCT02662348 is registered in ClinicalTrials.gov with Yi Miao as lead sponsor.

NCT NCT02662348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02662348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System
Lead sponsor
Yi Miao
Phase
Phase 1
Overall status
Unknown status
Start date
February 29, 2016
Completion date
November 30, 2017
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bowel cancer, esophageal cancer, gallbladder cancer, gastric cancer, liver cancer, pancreatic cancer